Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

8.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.2K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

9
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
9
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

22
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
22
Blinding01:11

Blinding

3.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.5K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

491
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
491
Longitudinal Studies01:26

Longitudinal Studies

283
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
283

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Lancet Commission on precision health: equitable, data-driven health outcomes for all.

Lancet (London, England)·2026
Same author

Testing Random Effects in Nonlinear Mixed-Effects Models.

Statistics in medicine·2026
Same author

Gilteritinib and chemotherapy in children with relapsed/refractory FLT3-ITD AML: results from the phase 1/2 SKIPPER trial.

Blood advances·2026
Same author

Digital Data Collection Reduces Terminal Digit Bias in Haemodynamic and Physical Activity Measures in Pulmonary Arterial Hypertension.

Pulmonary circulation·2026
Same author

Platform trial of smartphone-based cognitive-behavioural therapy (CBT) for depressive symptoms among people with no or subthreshold depression: a protocol for the Best, Efficient and Affordable Training in Resilience in Constant Evolution (BEATRICE) platform trial.

BMJ open·2026
Same author

Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid.

BMJ open·2026
Same journal

Sample Size Determination for Decision-centered Pragmatic Trials.

Journal of clinical epidemiology·2026
Same journal

Many multicenter randomized controlled trials do not account for center effect: a methodological review.

Journal of clinical epidemiology·2026
Same journal

Patient Acceptability of the Modified Zelen Approach to Randomized Trials - A Survey of the CAPS THA Cohort.

Journal of clinical epidemiology·2026
Same journal

Corrigendum to SPICE-GRADE: simultaneous processing of indirect causal evidence in complex pathways using GRADE - an exploratory case study. [Journal of Clinical Epidemiology, 194C (2026) 112219].

Journal of clinical epidemiology·2026
Same journal

Small numbers of clusters in cluster randomised trials: a scoping review of problems and proposed solutions.

Journal of clinical epidemiology·2026
Same journal

What's the Meta Now? More Updates on the Problems with Systematic Reviews.

Journal of clinical epidemiology·2026
See all related articles

Related Experiment Video

Updated: Oct 13, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

801

Sequential multiple assignment randomized trial studies should report all key components: a systematic review.

Theophile Bigirumurame1, Germaine Uwimpuhwe2, James Wason1

  • 1Biostatistics Research Group, Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, UK.

Journal of Clinical Epidemiology
|November 11, 2021
PubMed
Summary
This summary is machine-generated.

Sequential Multiple Assignment Randomized Trials (SMART) are powerful but often lack transparent reporting. Key design elements, like sample size calculations and adaptive intervention details, are frequently omitted, hindering interpretability.

Keywords:
Adaptive interventionAdaptive treatment strategiesDynamic treatment regimensMultistage treatment strategiesSequential multiple assignment randomized trialTreatment policies

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.3K

Related Experiment Videos

Last Updated: Oct 13, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

801
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.3K

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology
  • Health Services Research

Background:

  • Sequential Multiple Assignment Randomized Trial (SMART) designs offer flexibility for adaptive interventions and stage-specific research questions.
  • Assessing the reporting quality of SMART designs is crucial for ensuring their effective and transparent application.

Purpose of the Study:

  • To evaluate the quality of reporting for essential design parameters in Sequential Multiple Assignment Randomized Trial (SMART) studies.
  • To identify common omissions in the reporting of SMART trial features.

Main Methods:

  • A systematic literature search was conducted across four major databases (PubMed, Ovid, Web of Science, Scopus) up to June 15, 2020.
  • Included records comprised trial reports, protocols, reviews, and methodological papers mentioning SMART designs.

Main Results:

  • Out of 157 selected records, only 12 were trial reports; the majority were methodological papers (58%).
  • Few trials reported sample size calculation parameters (33.33%) or focused on determining optimal adaptive interventions (16.67%).
  • Information regarding multiple testing adjustments was largely absent, and designs primarily focused on stage-specific aims.

Conclusions:

  • Critical features of SMART designs are underreported and underutilized.
  • Inadequate reporting of design parameters limits the transparency and interpretability of studies employing SMART designs.